FDA chief proposes rules changes to fight high drug prices

Wall Street Journal

25 May 2017 - Gottlieb urges new regulations to ease generic drug entry to U.S. market

The new commissioner of the FDA plans a multifaceted effort to restrain high prescription-drug prices, centred on speeding cheaper generic medicines onto the U.S. market.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing